A18.84
|
Tuberculosis of heart
|
A36.81
|
Diphtheritic cardiomyopathy
|
A39.53
|
Meningococcal pericarditis
|
A40.0
|
Sepsis due to streptococcus, group A
|
A40.1
|
Sepsis due to streptococcus, group B
|
A40.3
|
Sepsis due to Streptococcus pneumoniae
|
A40.8
|
Other streptococcal sepsis
|
A40.9
|
Streptococcal sepsis, unspecified
|
A41.01
|
Sepsis due to Methicillin susceptible Staphylococcus aureus
|
A41.02
|
Sepsis due to Methicillin resistant Staphylococcus aureus
|
A41.1 - A41.4
|
Sepsis due to other specified staphylococcus - Sepsis due to anaerobes
|
A41.50 - A41.53
|
Gram-negative sepsis, unspecified - Sepsis due to Serratia
|
A41.59
|
Other Gram-negative sepsis
|
A41.81
|
Sepsis due to Enterococcus
|
A41.89
|
Other specified sepsis
|
A41.9
|
Sepsis, unspecified organism
|
A42.7
|
Actinomycotic sepsis
|
A52.01 - A52.03
|
Syphilitic aneurysm of aorta - Syphilitic endocarditis
|
A52.06
|
Other syphilitic heart involvement
|
A54.83
|
Gonococcal heart infection
|
A69.21 - A69.23
|
Meningitis due to Lyme disease - Arthritis due to Lyme disease
|
A69.29
|
Other conditions associated with Lyme disease
|
B33.20 - B33.23
|
Viral carditis, unspecified - Viral pericarditis
|
B37.6
|
Candidal endocarditis
|
B39.4*
|
Histoplasmosis capsulati, unspecified
|
B39.5*
|
Histoplasmosis duboisii
|
B57.0
|
Acute Chagas' disease with heart involvement
|
B57.2
|
Chagas' disease (chronic) with heart involvement
|
B58.81
|
Toxoplasma myocarditis
|
C38.0
|
Malignant neoplasm of heart
|
C45.2
|
Mesothelioma of pericardium
|
C79.89
|
Secondary malignant neoplasm of other specified sites
|
D15.1
|
Benign neoplasm of heart
|
D48.7
|
Neoplasm of uncertain behavior of other specified sites
|
D49.89
|
Neoplasm of unspecified behavior of other specified sites
|
D86.0 - D86.3
|
Sarcoidosis of lung - Sarcoidosis of skin
|
D86.81 - D86.87
|
Sarcoid meningitis - Sarcoid myositis
|
D86.89
|
Sarcoidosis of other sites
|
E03.5
|
Myxedema coma
|
E83.110
|
Hereditary hemochromatosis
|
E83.111
|
Hemochromatosis due to repeated red blood cell transfusions
|
E83.118
|
Other hemochromatosis
|
E83.19
|
Other disorders of iron metabolism
|
E85.0 - E85.4
|
Non-neuropathic heredofamilial amyloidosis - Organ-limited amyloidosis
|
E85.81
|
Light chain (AL) amyloidosis
|
E85.82
|
Wild-type transthyretin-related (ATTR) amyloidosis
|
E85.89
|
Other amyloidosis
|
E85.9
|
Amyloidosis, unspecified
|
G06.0
|
Intracranial abscess and granuloma
|
G06.1
|
Intraspinal abscess and granuloma
|
G45.0 - G45.3
|
Vertebro-basilar artery syndrome - Amaurosis fugax
|
G45.8
|
Other transient cerebral ischemic attacks and related syndromes
|
G45.9
|
Transient cerebral ischemic attack, unspecified
|
G46.0 - G46.2
|
Middle cerebral artery syndrome - Posterior cerebral artery syndrome
|
G47.30 - G47.33
|
Sleep apnea, unspecified - Obstructive sleep apnea (adult) (pediatric)
|
H34.01 - H34.03
|
Transient retinal artery occlusion, right eye - Transient retinal artery occlusion, bilateral
|
I01.0 - I01.2
|
Acute rheumatic pericarditis - Acute rheumatic myocarditis
|
I01.8
|
Other acute rheumatic heart disease
|
I01.9
|
Acute rheumatic heart disease, unspecified
|
I02.0
|
Rheumatic chorea with heart involvement
|
I02.9
|
Rheumatic chorea without heart involvement
|
I05.0 - I05.2
|
Rheumatic mitral stenosis - Rheumatic mitral stenosis with insufficiency
|
I05.8
|
Other rheumatic mitral valve diseases
|
I06.0 - I06.2
|
Rheumatic aortic stenosis - Rheumatic aortic stenosis with insufficiency
|
I06.8
|
Other rheumatic aortic valve diseases
|
I07.0 - I07.2
|
Rheumatic tricuspid stenosis - Rheumatic tricuspid stenosis and insufficiency
|
I07.8
|
Other rheumatic tricuspid valve diseases
|
I08.0 - I08.3
|
Rheumatic disorders of both mitral and aortic valves - Combined rheumatic disorders of mitral, aortic and tricuspid valves
|
I08.8
|
Other rheumatic multiple valve diseases
|
I08.9
|
Rheumatic multiple valve disease, unspecified
|
I09.0 - I09.2
|
Rheumatic myocarditis - Chronic rheumatic pericarditis
|
I09.81
|
Rheumatic heart failure
|
I09.89
|
Other specified rheumatic heart diseases
|
I11.0
|
Hypertensive heart disease with heart failure
|
I13.0
|
Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
|
I13.11
|
Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
|
I13.2
|
Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
|
I15.0
|
Renovascular hypertension
|
I15.1
|
Hypertension secondary to other renal disorders
|
I20.0
|
Unstable angina
|
I20.1
|
Angina pectoris with documented spasm
|
I20.81
|
Angina pectoris with coronary microvascular dysfunction
|
I20.89
|
Other forms of angina pectoris
|
I21.01
|
ST elevation (STEMI) myocardial infarction involving left main coronary artery
|
I21.02
|
ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
|
I21.09
|
ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall
|
I21.11
|
ST elevation (STEMI) myocardial infarction involving right coronary artery
|
I21.19
|
ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall
|
I21.21
|
ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery
|
I21.29
|
ST elevation (STEMI) myocardial infarction involving other sites
|
I21.3
|
ST elevation (STEMI) myocardial infarction of unspecified site
|
I21.4
|
Non-ST elevation (NSTEMI) myocardial infarction
|
I21.A1
|
Myocardial infarction type 2
|
I21.A9
|
Other myocardial infarction type
|
I22.0 - I22.2
|
Subsequent ST elevation (STEMI) myocardial infarction of anterior wall - Subsequent non-ST elevation (NSTEMI) myocardial infarction
|
I22.8
|
Subsequent ST elevation (STEMI) myocardial infarction of other sites
|
I22.9
|
Subsequent ST elevation (STEMI) myocardial infarction of unspecified site
|
I23.0 - I23.8
|
Hemopericardium as current complication following acute myocardial infarction - Other current complications following acute myocardial infarction
|
I24.0
|
Acute coronary thrombosis not resulting in myocardial infarction
|
I24.1
|
Dressler's syndrome
|
I24.81
|
Acute coronary microvascular dysfunction
|
I24.89
|
Other forms of acute ischemic heart disease
|
I25.10
|
Atherosclerotic heart disease of native coronary artery without angina pectoris
|
I25.110
|
Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
|
I25.111
|
Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm
|
I25.112
|
Atherosclerotic heart disease of native coronary artery with refractory angina pectoris
|
I25.118
|
Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris
|
I25.2
|
Old myocardial infarction
|
I25.3
|
Aneurysm of heart
|
I25.41
|
Coronary artery aneurysm
|
I25.42
|
Coronary artery dissection
|
I25.5
|
Ischemic cardiomyopathy
|
I25.6
|
Silent myocardial ischemia
|
I25.702
|
Atherosclerosis of coronary artery bypass graft(s), unspecified, with refractory angina pectoris
|
I25.710
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris
|
I25.711
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm
|
I25.712
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with refractory angina pectoris
|
I25.718
|
Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris
|
I25.720
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris
|
I25.721
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm
|
I25.722
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with refractory angina pectoris
|
I25.728
|
Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris
|
I25.730
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris
|
I25.731
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm
|
I25.732
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris
|
I25.738
|
Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris
|
I25.750
|
Atherosclerosis of native coronary artery of transplanted heart with unstable angina
|
I25.751
|
Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm
|
I25.752
|
Atherosclerosis of native coronary artery of transplanted heart with refractory angina pectoris
|
I25.758
|
Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris
|
I25.760
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina
|
I25.761
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm
|
I25.762
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with refractory angina pectoris
|
I25.768
|
Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris
|
I25.790
|
Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris
|
I25.791
|
Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm
|
I25.792
|
Atherosclerosis of other coronary artery bypass graft(s) with refractory angina pectoris
|
I25.798
|
Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris
|
I25.810 - I25.812
|
Atherosclerosis of coronary artery bypass graft(s) without angina pectoris - Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris
|
I25.82
|
Chronic total occlusion of coronary artery
|
I25.84
|
Coronary atherosclerosis due to calcified coronary lesion
|
I25.89
|
Other forms of chronic ischemic heart disease
|
I26.01
|
Septic pulmonary embolism with acute cor pulmonale
|
I26.02
|
Saddle embolus of pulmonary artery with acute cor pulmonale
|
I26.03
|
Cement embolism of pulmonary artery with acute cor pulmonale
|
I26.04
|
Fat embolism of pulmonary artery with acute cor pulmonale
|
I26.09
|
Other pulmonary embolism with acute cor pulmonale
|
I26.90
|
Septic pulmonary embolism without acute cor pulmonale
|
I26.92
|
Saddle embolus of pulmonary artery without acute cor pulmonale
|
I26.93
|
Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale
|
I26.94
|
Multiple subsegmental thrombotic pulmonary emboli without acute cor pulmonale
|
I26.95
|
Cement embolism of pulmonary artery without acute cor pulmonale
|
I26.96
|
Fat embolism of pulmonary artery without acute cor pulmonale
|
I26.99
|
Other pulmonary embolism without acute cor pulmonale
|
I27.0 - I27.1
|
Primary pulmonary hypertension - Kyphoscoliotic heart disease
|
I27.20
|
Pulmonary hypertension, unspecified
|
I27.21
|
Secondary pulmonary arterial hypertension
|
I27.22
|
Pulmonary hypertension due to left heart disease
|
I27.23
|
Pulmonary hypertension due to lung diseases and hypoxia
|
I27.24
|
Chronic thromboembolic pulmonary hypertension
|
I27.29
|
Other secondary pulmonary hypertension
|
I27.82
|
Chronic pulmonary embolism
|
I27.83
|
Eisenmenger's syndrome
|
I27.89
|
Other specified pulmonary heart diseases
|
I28.0
|
Arteriovenous fistula of pulmonary vessels
|
I28.1
|
Aneurysm of pulmonary artery
|
I30.0
|
Acute nonspecific idiopathic pericarditis
|
I30.1
|
Infective pericarditis
|
I30.8
|
Other forms of acute pericarditis
|
I31.0 - I31.4
|
Chronic adhesive pericarditis - Cardiac tamponade
|
I31.8
|
Other specified diseases of pericardium
|
I32
|
Pericarditis in diseases classified elsewhere
|
I33.0
|
Acute and subacute infective endocarditis
|
I33.9
|
Acute and subacute endocarditis, unspecified
|
I34.0 - I34.2
|
Nonrheumatic mitral (valve) insufficiency - Nonrheumatic mitral (valve) stenosis
|
I34.81
|
Nonrheumatic mitral (valve) annulus calcification
|
I34.89
|
Other nonrheumatic mitral valve disorders
|
I35.0 - I35.2
|
Nonrheumatic aortic (valve) stenosis - Nonrheumatic aortic (valve) stenosis with insufficiency
|
I35.8
|
Other nonrheumatic aortic valve disorders
|
I36.0 - I36.2
|
Nonrheumatic tricuspid (valve) stenosis - Nonrheumatic tricuspid (valve) stenosis with insufficiency
|
I36.8
|
Other nonrheumatic tricuspid valve disorders
|
I37.0 - I37.2
|
Nonrheumatic pulmonary valve stenosis - Nonrheumatic pulmonary valve stenosis with insufficiency
|
I37.8
|
Other nonrheumatic pulmonary valve disorders
|
I38
|
Endocarditis, valve unspecified
|
I39
|
Endocarditis and heart valve disorders in diseases classified elsewhere
|
I40.0
|
Infective myocarditis
|
I40.1
|
Isolated myocarditis
|
I40.8
|
Other acute myocarditis
|
I40.9
|
Acute myocarditis, unspecified
|
I41
|
Myocarditis in diseases classified elsewhere
|
I42.0 - I42.8
|
Dilated cardiomyopathy - Other cardiomyopathies
|
I43
|
Cardiomyopathy in diseases classified elsewhere
|
I44.1
|
Atrioventricular block, second degree
|
I44.2
|
Atrioventricular block, complete
|
I44.30
|
Unspecified atrioventricular block
|
I44.39
|
Other atrioventricular block
|
I44.7
|
Left bundle-branch block, unspecified
|
I45.2 - I45.6
|
Bifascicular block - Pre-excitation syndrome
|
I45.9
|
Conduction disorder, unspecified
|
I46.2
|
Cardiac arrest due to underlying cardiac condition
|
I46.8
|
Cardiac arrest due to other underlying condition
|
I46.9
|
Cardiac arrest, cause unspecified
|
I47.0
|
Re-entry ventricular arrhythmia
|
I47.11
|
Inappropriate sinus tachycardia, so stated
|
I47.19
|
Other supraventricular tachycardia
|
I47.21
|
Torsades de pointes
|
I47.29
|
Other ventricular tachycardia
|
I47.9
|
Paroxysmal tachycardia, unspecified
|
I48.0 - I48.4
|
Paroxysmal atrial fibrillation - Atypical atrial flutter
|
I49.01
|
Ventricular fibrillation
|
I49.02
|
Ventricular flutter
|
I49.1 - I49.3
|
Atrial premature depolarization - Ventricular premature depolarization
|
I49.40
|
Unspecified premature depolarization
|
I49.49
|
Other premature depolarization
|
I50.1
|
Left ventricular failure, unspecified
|
I50.21 - I50.23
|
Acute systolic (congestive) heart failure - Acute on chronic systolic (congestive) heart failure
|
I50.31 - I50.33
|
Acute diastolic (congestive) heart failure - Acute on chronic diastolic (congestive) heart failure
|
I50.41 - I50.43
|
Acute combined systolic (congestive) and diastolic (congestive) heart failure - Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
|
I51.0 - I51.5
|
Cardiac septal defect, acquired - Myocardial degeneration
|
I51.7
|
Cardiomegaly
|
I51.81
|
Takotsubo syndrome
|
I51.89
|
Other ill-defined heart diseases
|
I51.9
|
Heart disease, unspecified
|
I52
|
Other heart disorders in diseases classified elsewhere
|
I60.01
|
Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation
|
I60.02
|
Nontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation
|
I60.11
|
Nontraumatic subarachnoid hemorrhage from right middle cerebral artery
|
I60.12
|
Nontraumatic subarachnoid hemorrhage from left middle cerebral artery
|
I60.31
|
Nontraumatic subarachnoid hemorrhage from right posterior communicating artery
|
I60.32
|
Nontraumatic subarachnoid hemorrhage from left posterior communicating artery
|
I60.4
|
Nontraumatic subarachnoid hemorrhage from basilar artery
|
I60.51
|
Nontraumatic subarachnoid hemorrhage from right vertebral artery
|
I60.52
|
Nontraumatic subarachnoid hemorrhage from left vertebral artery
|
I60.6
|
Nontraumatic subarachnoid hemorrhage from other intracranial arteries
|
I60.7
|
Nontraumatic subarachnoid hemorrhage from unspecified intracranial artery
|
I60.8
|
Other nontraumatic subarachnoid hemorrhage
|
I63.311
|
Cerebral infarction due to thrombosis of right middle cerebral artery
|
I63.312
|
Cerebral infarction due to thrombosis of left middle cerebral artery
|
I63.321
|
Cerebral infarction due to thrombosis of right anterior cerebral artery
|
I63.322
|
Cerebral infarction due to thrombosis of left anterior cerebral artery
|
I63.331
|
Cerebral infarction due to thrombosis of right posterior cerebral artery
|
I63.332
|
Cerebral infarction due to thrombosis of left posterior cerebral artery
|
I63.341
|
Cerebral infarction due to thrombosis of right cerebellar artery
|
I63.342
|
Cerebral infarction due to thrombosis of left cerebellar artery
|
I63.39
|
Cerebral infarction due to thrombosis of other cerebral artery
|
I63.411
|
Cerebral infarction due to embolism of right middle cerebral artery
|
I63.412
|
Cerebral infarction due to embolism of left middle cerebral artery
|
I63.421
|
Cerebral infarction due to embolism of right anterior cerebral artery
|
I63.422
|
Cerebral infarction due to embolism of left anterior cerebral artery
|
I63.431
|
Cerebral infarction due to embolism of right posterior cerebral artery
|
I63.432
|
Cerebral infarction due to embolism of left posterior cerebral artery
|
I63.441
|
Cerebral infarction due to embolism of right cerebellar artery
|
I63.442
|
Cerebral infarction due to embolism of left cerebellar artery
|
I63.49
|
Cerebral infarction due to embolism of other cerebral artery
|
I63.511
|
Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery
|
I63.512
|
Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery
|
I63.521
|
Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery
|
I63.522
|
Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery
|
I63.531
|
Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery
|
I63.532
|
Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery
|
I63.541
|
Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery
|
I63.542
|
Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery
|
I63.59
|
Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery
|
I63.6
|
Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
|
I63.81
|
Other cerebral infarction due to occlusion or stenosis of small artery
|
I63.89
|
Other cerebral infarction
|
I66.01 - I66.03
|
Occlusion and stenosis of right middle cerebral artery - Occlusion and stenosis of bilateral middle cerebral arteries
|
I66.11 - I66.13
|
Occlusion and stenosis of right anterior cerebral artery - Occlusion and stenosis of bilateral anterior cerebral arteries
|
I66.21 - I66.23
|
Occlusion and stenosis of right posterior cerebral artery - Occlusion and stenosis of bilateral posterior cerebral arteries
|
I66.3
|
Occlusion and stenosis of cerebellar arteries
|
I66.8
|
Occlusion and stenosis of other cerebral arteries
|
I67.841
|
Reversible cerebrovascular vasoconstriction syndrome
|
I67.848
|
Other cerebrovascular vasospasm and vasoconstriction
|
I67.850
|
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
|
I67.858
|
Other hereditary cerebrovascular disease
|
I67.89
|
Other cerebrovascular disease
|
I70.0
|
Atherosclerosis of aorta
|
I71.00 - I71.03
|
Dissection of unspecified site of aorta - Dissection of thoracoabdominal aorta
|
I71.11
|
Aneurysm of the ascending aorta, ruptured
|
I71.12
|
Aneurysm of the aortic arch, ruptured
|
I71.13
|
Aneurysm of the descending thoracic aorta, ruptured
|
I71.21
|
Aneurysm of the ascending aorta, without rupture
|
I71.22
|
Aneurysm of the aortic arch, without rupture
|
I71.23
|
Aneurysm of the descending thoracic aorta, without rupture
|
I71.31
|
Pararenal abdominal aortic aneurysm, ruptured
|
I71.32
|
Juxtarenal abdominal aortic aneurysm, ruptured
|
I71.33
|
Infrarenal abdominal aortic aneurysm, ruptured
|
I71.41
|
Pararenal abdominal aortic aneurysm, without rupture
|
I71.42
|
Juxtarenal abdominal aortic aneurysm, without rupture
|
I71.43
|
Infrarenal abdominal aortic aneurysm, without rupture
|
I71.51
|
Supraceliac aneurysm of the thoracoabdominal aorta, ruptured
|
I71.52
|
Paravisceral aneurysm of the thoracoabdominal aorta, ruptured
|
I71.61
|
Supraceliac aneurysm of the thoracoabdominal aorta, without rupture
|
I71.62
|
Paravisceral aneurysm of the thoracoabdominal aorta, without rupture
|
I71.8
|
Aortic aneurysm of unspecified site, ruptured
|
I74.11
|
Embolism and thrombosis of thoracic aorta
|
I74.2 - I74.5
|
Embolism and thrombosis of arteries of the upper extremities - Embolism and thrombosis of iliac artery
|
I74.8
|
Embolism and thrombosis of other arteries
|
I74.9
|
Embolism and thrombosis of unspecified artery
|
I76
|
Septic arterial embolism
|
I77.810
|
Thoracic aortic ectasia
|
I79.0
|
Aneurysm of aorta in diseases classified elsewhere
|
I95.1
|
Orthostatic hypotension
|
I95.2
|
Hypotension due to drugs
|
I95.81
|
Postprocedural hypotension
|
I95.89
|
Other hypotension
|
I95.9
|
Hypotension, unspecified
|
I97.0
|
Postcardiotomy syndrome
|
I97.110
|
Postprocedural cardiac insufficiency following cardiac surgery
|
I97.111
|
Postprocedural cardiac insufficiency following other surgery
|
I97.120
|
Postprocedural cardiac arrest following cardiac surgery
|
I97.121
|
Postprocedural cardiac arrest following other surgery
|
I97.130
|
Postprocedural heart failure following cardiac surgery
|
I97.131
|
Postprocedural heart failure following other surgery
|
I97.190
|
Other postprocedural cardiac functional disturbances following cardiac surgery
|
I97.191
|
Other postprocedural cardiac functional disturbances following other surgery
|
I97.710
|
Intraoperative cardiac arrest during cardiac surgery
|
I97.711
|
Intraoperative cardiac arrest during other surgery
|
I97.790
|
Other intraoperative cardiac functional disturbances during cardiac surgery
|
I97.791
|
Other intraoperative cardiac functional disturbances during other surgery
|
I97.88
|
Other intraoperative complications of the circulatory system, not elsewhere classified
|
I97.89
|
Other postprocedural complications and disorders of the circulatory system, not elsewhere classified
|
J80
|
Acute respiratory distress syndrome
|
J81.0
|
Acute pulmonary edema
|
J95.1 - J95.3
|
Acute pulmonary insufficiency following thoracic surgery - Chronic pulmonary insufficiency following surgery
|
J95.821
|
Acute postprocedural respiratory failure
|
J95.822
|
Acute and chronic postprocedural respiratory failure
|
J95.84
|
Transfusion-related acute lung injury (TRALI)
|
J96.01
|
Acute respiratory failure with hypoxia
|
J96.02
|
Acute respiratory failure with hypercapnia
|
J96.21
|
Acute and chronic respiratory failure with hypoxia
|
J96.22
|
Acute and chronic respiratory failure with hypercapnia
|
K68.11
|
Postprocedural retroperitoneal abscess
|
M30.3
|
Mucocutaneous lymph node syndrome [Kawasaki]
|
M31.4
|
Aortic arch syndrome [Takayasu]
|
M32.0
|
Drug-induced systemic lupus erythematosus
|
M32.11 - M32.15
|
Endocarditis in systemic lupus erythematosus - Tubulo-interstitial nephropathy in systemic lupus erythematosus
|
M32.19
|
Other organ or system involvement in systemic lupus erythematosus
|
M32.8
|
Other forms of systemic lupus erythematosus
|
M32.9
|
Systemic lupus erythematosus, unspecified
|
N26.2
|
Page kidney
|
N98.0
|
Infection associated with artificial insemination
|
O90.3
|
Peripartum cardiomyopathy
|
O90.89
|
Other complications of the puerperium, not elsewhere classified
|
Q20.2
|
Double outlet left ventricle
|
Q20.3
|
Discordant ventriculoarterial connection
|
Q20.5
|
Discordant atrioventricular connection
|
Q20.8
|
Other congenital malformations of cardiac chambers and connections
|
Q21.0
|
Ventricular septal defect
|
Q21.11 - Q21.15
|
Secundum atrial septal defect - Inferior sinus venosus atrial septal defect
|
Q21.19
|
Other specified atrial septal defect
|
Q21.20 - Q21.4
|
Atrioventricular septal defect, unspecified as to partial or complete - Aortopulmonary septal defect
|
Q21.9
|
Congenital malformation of cardiac septum, unspecified
|
Q22.1 - Q22.6
|
Congenital pulmonary valve stenosis - Hypoplastic right heart syndrome
|
Q22.8
|
Other congenital malformations of tricuspid valve
|
Q23.0 - Q23.3
|
Congenital stenosis of aortic valve - Congenital mitral insufficiency
|
Q23.81
|
Bicuspid aortic valve
|
Q23.82
|
Congenital mitral valve cleft leaflet
|
Q23.88
|
Other congenital malformations of aortic and mitral valves
|
Q24.0 - Q24.4
|
Dextrocardia - Congenital subaortic stenosis
|
Q24.6
|
Congenital heart block
|
Q24.8
|
Other specified congenital malformations of heart
|
Q25.0
|
Patent ductus arteriosus
|
Q25.1
|
Coarctation of aorta
|
Q25.21
|
Interruption of aortic arch
|
Q25.29
|
Other atresia of aorta
|
Q25.3
|
Supravalvular aortic stenosis
|
Q25.41
|
Absence and aplasia of aorta
|
Q25.42
|
Hypoplasia of aorta
|
Q25.43
|
Congenital aneurysm of aorta
|
Q25.44
|
Congenital dilation of aorta
|
Q25.45
|
Double aortic arch
|
Q25.46
|
Tortuous aortic arch
|
Q25.47
|
Right aortic arch
|
Q25.48
|
Anomalous origin of subclavian artery
|
Q25.49
|
Other congenital malformations of aorta
|
Q25.5
|
Atresia of pulmonary artery
|
Q25.6
|
Stenosis of pulmonary artery
|
Q25.71
|
Coarctation of pulmonary artery
|
Q25.72
|
Congenital pulmonary arteriovenous malformation
|
Q25.79
|
Other congenital malformations of pulmonary artery
|
Q25.8
|
Other congenital malformations of other great arteries
|
Q26.0 - Q26.4
|
Congenital stenosis of vena cava - Anomalous pulmonary venous connection, unspecified
|
Q26.8
|
Other congenital malformations of great veins
|
Q26.9
|
Congenital malformation of great vein, unspecified
|
Q27.9
|
Congenital malformation of peripheral vascular system, unspecified
|
Q28.2
|
Arteriovenous malformation of cerebral vessels
|
Q28.3
|
Other malformations of cerebral vessels
|
Q87.410
|
Marfan syndrome with aortic dilation
|
Q87.418
|
Marfan syndrome with other cardiovascular manifestations
|
Q87.42
|
Marfan syndrome with ocular manifestations
|
Q87.43
|
Marfan syndrome with skeletal manifestation
|
Q89.01
|
Asplenia (congenital)
|
Q89.09
|
Congenital malformations of spleen
|
Q89.3
|
Situs inversus
|
Q89.9
|
Congenital malformation, unspecified
|
Q90.0 - Q90.2
|
Trisomy 21, nonmosaicism (meiotic nondisjunction) - Trisomy 21, translocation
|
Q96.0 - Q96.4
|
Karyotype 45, X - Mosaicism, 45, X/other cell line(s) with abnormal sex chromosome
|
Q96.8
|
Other variants of Turner's syndrome
|
R00.2
|
Palpitations
|
R00.8
|
Other abnormalities of heart beat
|
R01.0 - R01.2
|
Benign and innocent cardiac murmurs - Other cardiac sounds
|
R06.00
|
Dyspnea, unspecified
|
R06.02
|
Shortness of breath
|
R06.09
|
Other forms of dyspnea
|
R06.2
|
Wheezing
|
R06.3
|
Periodic breathing
|
R06.81 - R06.83
|
Apnea, not elsewhere classified - Snoring
|
R06.89
|
Other abnormalities of breathing
|
R07.2
|
Precordial pain
|
R07.82
|
Intercostal pain
|
R07.89
|
Other chest pain
|
R07.9
|
Chest pain, unspecified
|
R09.2
|
Respiratory arrest
|
R22.2
|
Localized swelling, mass and lump, trunk
|
R23.0
|
Cyanosis
|
R40.20
|
Unspecified coma
|
R40.2111 - R40.2114
|
Coma scale, eyes open, never, in the field [EMT or ambulance] - Coma scale, eyes open, never, 24 hours or more after hospital admission
|
R40.2121 - R40.2124
|
Coma scale, eyes open, to pain, in the field [EMT or ambulance] - Coma scale, eyes open, to pain, 24 hours or more after hospital admission
|
R40.2211 - R40.2214
|
Coma scale, best verbal response, none, in the field [EMT or ambulance] - Coma scale, best verbal response, none, 24 hours or more after hospital admission
|
R40.2221 - R40.2224
|
Coma scale, best verbal response, incomprehensible words, in the field [EMT or ambulance] - Coma scale, best verbal response, incomprehensible words, 24 hours or more after hospital admission
|
R40.2311 - R40.2314
|
Coma scale, best motor response, none, in the field [EMT or ambulance] - Coma scale, best motor response, none, 24 hours or more after hospital admission
|
R40.2321 - R40.2324
|
Coma scale, best motor response, extension, in the field [EMT or ambulance] - Coma scale, best motor response, extension, 24 hours or more after hospital admission
|
R40.2341 - R40.2344
|
Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance] - Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admission
|
R40.4
|
Transient alteration of awareness
|
R47.01
|
Aphasia
|
R50.2
|
Drug induced fever
|
R50.81
|
Fever presenting with conditions classified elsewhere
|
R50.82
|
Postprocedural fever
|
R50.9
|
Fever, unspecified
|
R55
|
Syncope and collapse
|
R57.0
|
Cardiogenic shock
|
R57.1
|
Hypovolemic shock
|
R57.8
|
Other shock
|
R57.9
|
Shock, unspecified
|
R60.0
|
Localized edema
|
R60.1
|
Generalized edema
|
R65.21
|
Severe sepsis with septic shock
|
R68.89
|
Other general symptoms and signs
|
R78.81
|
Bacteremia
|
R94.31
|
Abnormal electrocardiogram [ECG] [EKG]
|
S12.000B*
|
Unspecified displaced fracture of first cervical vertebra, initial encounter for open fracture
|
S12.001B*
|
Unspecified nondisplaced fracture of first cervical vertebra, initial encounter for open fracture
|
S12.100B*
|
Unspecified displaced fracture of second cervical vertebra, initial encounter for open fracture
|
S12.101B*
|
Unspecified nondisplaced fracture of second cervical vertebra, initial encounter for open fracture
|
S12.200B*
|
Unspecified displaced fracture of third cervical vertebra, initial encounter for open fracture
|
S12.201B*
|
Unspecified nondisplaced fracture of third cervical vertebra, initial encounter for open fracture
|
S12.300B*
|
Unspecified displaced fracture of fourth cervical vertebra, initial encounter for open fracture
|
S12.301B*
|
Unspecified nondisplaced fracture of fourth cervical vertebra, initial encounter for open fracture
|
S14.111A*
|
Complete lesion at C1 level of cervical spinal cord, initial encounter
|
S14.112A*
|
Complete lesion at C2 level of cervical spinal cord, initial encounter
|
S14.113A*
|
Complete lesion at C3 level of cervical spinal cord, initial encounter
|
S14.114A*
|
Complete lesion at C4 level of cervical spinal cord, initial encounter
|
S14.121A*
|
Central cord syndrome at C1 level of cervical spinal cord, initial encounter
|
S14.122A*
|
Central cord syndrome at C2 level of cervical spinal cord, initial encounter
|
S14.123A*
|
Central cord syndrome at C3 level of cervical spinal cord, initial encounter
|
S14.124A*
|
Central cord syndrome at C4 level of cervical spinal cord, initial encounter
|
S21.309A*
|
Unspecified open wound of unspecified front wall of thorax with penetration into thoracic cavity, initial encounter
|
S22.5XXA
|
Flail chest, initial encounter for closed fracture
|
S22.5XXB
|
Flail chest, initial encounter for open fracture
|
S25.01XA
|
Minor laceration of thoracic aorta, initial encounter
|
S25.02XA
|
Major laceration of thoracic aorta, initial encounter
|
S25.09XA
|
Other specified injury of thoracic aorta, initial encounter
|
S25.21XA
|
Minor laceration of superior vena cava, initial encounter
|
S25.22XA
|
Major laceration of superior vena cava, initial encounter
|
S25.29XA
|
Other specified injury of superior vena cava, initial encounter
|
S25.401A
|
Unspecified injury of right pulmonary blood vessels, initial encounter
|
S25.402A
|
Unspecified injury of left pulmonary blood vessels, initial encounter
|
S25.411A
|
Minor laceration of right pulmonary blood vessels, initial encounter
|
S25.412A
|
Minor laceration of left pulmonary blood vessels, initial encounter
|
S25.421A
|
Major laceration of right pulmonary blood vessels, initial encounter
|
S25.422A
|
Major laceration of left pulmonary blood vessels, initial encounter
|
S25.491A
|
Other specified injury of right pulmonary blood vessels, initial encounter
|
S25.492A
|
Other specified injury of left pulmonary blood vessels, initial encounter
|
S26.00XA
|
Unspecified injury of heart with hemopericardium, initial encounter
|
S26.01XA
|
Contusion of heart with hemopericardium, initial encounter
|
S26.020A
|
Mild laceration of heart with hemopericardium, initial encounter
|
S26.021A
|
Moderate laceration of heart with hemopericardium, initial encounter
|
S26.022A
|
Major laceration of heart with hemopericardium, initial encounter
|
S26.09XA
|
Other injury of heart with hemopericardium, initial encounter
|
S26.10XA
|
Unspecified injury of heart without hemopericardium, initial encounter
|
S26.11XA
|
Contusion of heart without hemopericardium, initial encounter
|
S26.12XA
|
Laceration of heart without hemopericardium, initial encounter
|
S26.19XA
|
Other injury of heart without hemopericardium, initial encounter
|
S26.90XA*
|
Unspecified injury of heart, unspecified with or without hemopericardium, initial encounter
|
S26.92XA*
|
Laceration of heart, unspecified with or without hemopericardium, initial encounter
|
S29.091A
|
Other injury of muscle and tendon of front wall of thorax, initial encounter
|
S29.092A
|
Other injury of muscle and tendon of back wall of thorax, initial encounter
|
S29.8XXA
|
Other specified injuries of thorax, initial encounter
|
T36.0X5A
|
Adverse effect of penicillins, initial encounter
|
T36.1X5A
|
Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
|
T36.2X5A
|
Adverse effect of chloramphenicol group, initial encounter
|
T36.3X5A
|
Adverse effect of macrolides, initial encounter
|
T36.4X5A
|
Adverse effect of tetracyclines, initial encounter
|
T36.5X5A
|
Adverse effect of aminoglycosides, initial encounter
|
T36.6X5A
|
Adverse effect of rifampicins, initial encounter
|
T36.7X5A
|
Adverse effect of antifungal antibiotics, systemically used, initial encounter
|
T36.8X5A
|
Adverse effect of other systemic antibiotics, initial encounter
|
T37.0X5A
|
Adverse effect of sulfonamides, initial encounter
|
T37.1X5A
|
Adverse effect of antimycobacterial drugs, initial encounter
|
T37.2X5A
|
Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
|
T37.3X5A
|
Adverse effect of other antiprotozoal drugs, initial encounter
|
T37.4X5A
|
Adverse effect of anthelminthics, initial encounter
|
T37.5X5A
|
Adverse effect of antiviral drugs, initial encounter
|
T37.8X5A
|
Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
|
T38.0X1A
|
Poisoning by glucocorticoids and synthetic analogues, accidental (unintentional), initial encounter
|
T38.0X2A
|
Poisoning by glucocorticoids and synthetic analogues, intentional self-harm, initial encounter
|
T38.0X3A
|
Poisoning by glucocorticoids and synthetic analogues, assault, initial encounter
|
T38.0X5A
|
Adverse effect of glucocorticoids and synthetic analogues, initial encounter
|
T38.1X5A
|
Adverse effect of thyroid hormones and substitutes, initial encounter
|
T38.2X5A
|
Adverse effect of antithyroid drugs, initial encounter
|
T38.4X5A
|
Adverse effect of oral contraceptives, initial encounter
|
T38.5X5A
|
Adverse effect of other estrogens and progestogens, initial encounter
|
T38.6X5A
|
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
|
T38.7X5A
|
Adverse effect of androgens and anabolic congeners, initial encounter
|
T38.815A
|
Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
|
T38.895A
|
Adverse effect of other hormones and synthetic substitutes, initial encounter
|
T38.995A
|
Adverse effect of other hormone antagonists, initial encounter
|
T39.015A
|
Adverse effect of aspirin, initial encounter
|
T39.095A
|
Adverse effect of salicylates, initial encounter
|
T39.1X5A
|
Adverse effect of 4-Aminophenol derivatives, initial encounter
|
T39.2X5A
|
Adverse effect of pyrazolone derivatives, initial encounter
|
T39.315A
|
Adverse effect of propionic acid derivatives, initial encounter
|
T39.395A
|
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
|
T39.4X5A
|
Adverse effect of antirheumatics, not elsewhere classified, initial encounter
|
T39.8X5A
|
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
|
T40.0X5A
|
Adverse effect of opium, initial encounter
|
T40.2X1A
|
Poisoning by other opioids, accidental (unintentional), initial encounter
|
T40.2X3A
|
Poisoning by other opioids, assault, initial encounter
|
T40.2X4A
|
Poisoning by other opioids, undetermined, initial encounter
|
T40.2X5A
|
Adverse effect of other opioids, initial encounter
|
T40.3X5A
|
Adverse effect of methadone, initial encounter
|
T40.491A
|
Poisoning by other synthetic narcotics, accidental (unintentional), initial encounter
|
T40.492A
|
Poisoning by other synthetic narcotics, intentional self-harm, initial encounter
|
T40.493A
|
Poisoning by other synthetic narcotics, assault, initial encounter
|
T40.495A
|
Adverse effect of other synthetic narcotics, initial encounter
|
T40.5X5A
|
Adverse effect of cocaine, initial encounter
|
T40.691A
|
Poisoning by other narcotics, accidental (unintentional), initial encounter
|
T40.692A
|
Poisoning by other narcotics, intentional self-harm, initial encounter
|
T40.693A
|
Poisoning by other narcotics, assault, initial encounter
|
T40.695A
|
Adverse effect of other narcotics, initial encounter
|
T40.715A
|
Adverse effect of cannabis, initial encounter
|
T40.725A
|
Adverse effect of synthetic cannabinoids, initial encounter
|
T40.995A
|
Adverse effect of other psychodysleptics [hallucinogens], initial encounter
|
T41.0X5A
|
Adverse effect of inhaled anesthetics, initial encounter
|
T41.1X5A
|
Adverse effect of intravenous anesthetics, initial encounter
|
T41.295A
|
Adverse effect of other general anesthetics, initial encounter
|
T41.3X5A
|
Adverse effect of local anesthetics, initial encounter
|
T41.5X5A
|
Adverse effect of therapeutic gases, initial encounter
|
T42.0X5A
|
Adverse effect of hydantoin derivatives, initial encounter
|
T42.1X5A
|
Adverse effect of iminostilbenes, initial encounter
|
T42.2X5A
|
Adverse effect of succinimides and oxazolidinediones, initial encounter
|
T42.3X5A
|
Adverse effect of barbiturates, initial encounter
|
T42.4X5A
|
Adverse effect of benzodiazepines, initial encounter
|
T42.5X5A
|
Adverse effect of mixed antiepileptics, initial encounter
|
T42.6X5A
|
Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
|
T42.8X5A
|
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
|
T43.015A
|
Adverse effect of tricyclic antidepressants, initial encounter
|
T43.025A
|
Adverse effect of tetracyclic antidepressants, initial encounter
|
T43.1X5A
|
Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
|
T43.215A
|
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
|
T43.225A
|
Adverse effect of selective serotonin reuptake inhibitors, initial encounter
|
T43.295A
|
Adverse effect of other antidepressants, initial encounter
|
T43.3X5A
|
Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
|
T43.4X5A
|
Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
|
T43.595A
|
Adverse effect of other antipsychotics and neuroleptics, initial encounter
|
T43.615A
|
Adverse effect of caffeine, initial encounter
|
T43.625A
|
Adverse effect of amphetamines, initial encounter
|
T43.635A
|
Adverse effect of methylphenidate, initial encounter
|
T43.641A
|
Poisoning by ecstasy, accidental (unintentional), initial encounter
|
T43.641D
|
Poisoning by ecstasy, accidental (unintentional), subsequent encounter
|
T43.641S
|
Poisoning by ecstasy, accidental (unintentional), sequela
|
T43.642A
|
Poisoning by ecstasy, intentional self-harm, initial encounter
|
T43.642D
|
Poisoning by ecstasy, intentional self-harm, subsequent encounter
|
T43.642S
|
Poisoning by ecstasy, intentional self-harm, sequela
|
T43.643A
|
Poisoning by ecstasy, assault, initial encounter
|
T43.643D
|
Poisoning by ecstasy, assault, subsequent encounter
|
T43.643S
|
Poisoning by ecstasy, assault, sequela
|
T43.644A
|
Poisoning by ecstasy, undetermined, initial encounter
|
T43.644D
|
Poisoning by ecstasy, undetermined, subsequent encounter
|
T43.644S
|
Poisoning by ecstasy, undetermined, sequela
|
T43.651A
|
Poisoning by methamphetamines accidental (unintentional), initial encounter
|
T43.651D
|
Poisoning by methamphetamines accidental (unintentional), subsequent encounter
|
T43.651S
|
Poisoning by methamphetamines accidental (unintentional), sequela
|
T43.652A
|
Poisoning by methamphetamines intentional self-harm, initial encounter
|
T43.652D
|
Poisoning by methamphetamines intentional self-harm, subsequent encounter
|
T43.652S
|
Poisoning by methamphetamines intentional self-harm, sequela
|
T43.653A
|
Poisoning by methamphetamines, assault, initial encounter
|
T43.653D
|
Poisoning by methamphetamines, assault, subsequent encounter
|
T43.653S
|
Poisoning by methamphetamines, assault, sequela
|
T43.654A
|
Poisoning by methamphetamines, undetermined, initial encounter
|
T43.654D
|
Poisoning by methamphetamines, undetermined, subsequent encounter
|
T43.654S
|
Poisoning by methamphetamines, undetermined, sequela
|
T43.655A
|
Adverse effect of methamphetamines, initial encounter
|
T43.655D
|
Adverse effect of methamphetamines, subsequent encounter
|
T43.655S
|
Adverse effect of methamphetamines, sequela
|
T43.656A
|
Underdosing of methamphetamines, initial encounter
|
T43.656D
|
Underdosing of methamphetamines, subsequent encounter
|
T43.656S
|
Underdosing of methamphetamines, sequela
|
T43.695A
|
Adverse effect of other psychostimulants, initial encounter
|
T43.8X5A
|
Adverse effect of other psychotropic drugs, initial encounter
|
T44.0X5A
|
Adverse effect of anticholinesterase agents, initial encounter
|
T44.1X5A
|
Adverse effect of other parasympathomimetics [cholinergics], initial encounter
|
T44.2X1A
|
Poisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter
|
T44.2X2A
|
Poisoning by ganglionic blocking drugs, intentional self-harm, initial encounter
|
T44.2X3A
|
Poisoning by ganglionic blocking drugs, assault, initial encounter
|
T44.2X5A
|
Adverse effect of ganglionic blocking drugs, initial encounter
|
T44.3X5A
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
|
T44.4X5A
|
Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
|
T44.5X5A
|
Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
|
T44.6X5A
|
Adverse effect of alpha-adrenoreceptor antagonists, initial encounter
|
T44.7X5A
|
Adverse effect of beta-adrenoreceptor antagonists, initial encounter
|
T44.8X5A
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
|
T44.995A
|
Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
|
T45.0X1A
|
Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
|
T45.0X2A
|
Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
|
T45.0X3A
|
Poisoning by antiallergic and antiemetic drugs, assault, initial encounter
|
T45.0X5A
|
Adverse effect of antiallergic and antiemetic drugs, initial encounter
|
T45.1X1A
|
Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter
|
T45.1X2A
|
Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter
|
T45.1X3A
|
Poisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
|
T45.1X5A
|
Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
|
T45.1X5S
|
Adverse effect of antineoplastic and immunosuppressive drugs, sequela
|
T45.2X5A
|
Adverse effect of vitamins, initial encounter
|
T45.3X5A
|
Adverse effect of enzymes, initial encounter
|
T45.4X5A
|
Adverse effect of iron and its compounds, initial encounter
|
T45.515A
|
Adverse effect of anticoagulants, initial encounter
|
T45.525A
|
Adverse effect of antithrombotic drugs, initial encounter
|
T45.615A
|
Adverse effect of thrombolytic drugs, initial encounter
|
T45.625A
|
Adverse effect of hemostatic drug, initial encounter
|
T45.695A
|
Adverse effect of other fibrinolysis-affecting drugs, initial encounter
|
T45.7X5A
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
|
T45.8X5A
|
Adverse effect of other primarily systemic and hematological agents, initial encounter
|
T46.0X1A
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
|
T46.0X2A
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
|
T46.0X3A
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
|
T46.0X5A
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
|
T46.1X1A
|
Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter
|
T46.1X2A
|
Poisoning by calcium-channel blockers, intentional self-harm, initial encounter
|
T46.1X3A
|
Poisoning by calcium-channel blockers, assault, initial encounter
|
T46.1X5A
|
Adverse effect of calcium-channel blockers, initial encounter
|
T46.2X1A
|
Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
|
T46.2X2A
|
Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
|
T46.2X3A
|
Poisoning by other antidysrhythmic drugs, assault, initial encounter
|
T46.2X5A
|
Adverse effect of other antidysrhythmic drugs, initial encounter
|
T46.3X1A
|
Poisoning by coronary vasodilators, accidental (unintentional), initial encounter
|
T46.3X2A
|
Poisoning by coronary vasodilators, intentional self-harm, initial encounter
|
T46.3X3A
|
Poisoning by coronary vasodilators, assault, initial encounter
|
T46.3X5A
|
Adverse effect of coronary vasodilators, initial encounter
|
T46.4X1A
|
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
|
T46.4X2A
|
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
|
T46.4X3A
|
Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
|
T46.4X5A
|
Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
|
T46.5X1A
|
Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
|
T46.5X2A
|
Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter
|
T46.5X3A
|
Poisoning by other antihypertensive drugs, assault, initial encounter
|
T46.5X5A
|
Adverse effect of other antihypertensive drugs, initial encounter
|
T46.6X1A
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
|
T46.6X2A
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
|
T46.6X3A
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter
|
T46.6X5A
|
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
|
T46.7X1A
|
Poisoning by peripheral vasodilators, accidental (unintentional), initial encounter
|
T46.7X2A
|
Poisoning by peripheral vasodilators, intentional self-harm, initial encounter
|
T46.7X3A
|
Poisoning by peripheral vasodilators, assault, initial encounter
|
T46.7X5A
|
Adverse effect of peripheral vasodilators, initial encounter
|
T46.8X1A
|
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
|
T46.8X2A
|
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
|
T46.8X3A
|
Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
|
T46.8X5A
|
Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
|
T46.901A
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
|
T46.902A
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
|
T46.903A
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
|
T46.905A
|
Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
|
T46.991A
|
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
|
T46.992A
|
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
|
T46.993A
|
Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
|
T46.995A
|
Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
|
T47.0X5A
|
Adverse effect of histamine H2-receptor blockers, initial encounter
|
T47.1X5A
|
Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
|
T47.2X5A
|
Adverse effect of stimulant laxatives, initial encounter
|
T47.3X5A
|
Adverse effect of saline and osmotic laxatives, initial encounter
|
T47.4X5A
|
Adverse effect of other laxatives, initial encounter
|
T47.5X5A
|
Adverse effect of digestants, initial encounter
|
T47.6X5A
|
Adverse effect of antidiarrheal drugs, initial encounter
|
T47.7X5A
|
Adverse effect of emetics, initial encounter
|
T47.8X5A
|
Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
|
T48.0X5A
|
Adverse effect of oxytocic drugs, initial encounter
|
T48.1X5A
|
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
|
T48.295A
|
Adverse effect of other drugs acting on muscles, initial encounter
|
T48.3X5A
|
Adverse effect of antitussives, initial encounter
|
T48.4X5A
|
Adverse effect of expectorants, initial encounter
|
T48.5X5A
|
Adverse effect of other anti-common-cold drugs, initial encounter
|
T48.6X5A
|
Adverse effect of antiasthmatics, initial encounter
|
T48.995A
|
Adverse effect of other agents primarily acting on the respiratory system, initial encounter
|
T49.0X5A
|
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
|
T49.1X5A
|
Adverse effect of antipruritics, initial encounter
|
T49.2X5A
|
Adverse effect of local astringents and local detergents, initial encounter
|
T49.3X5A
|
Adverse effect of emollients, demulcents and protectants, initial encounter
|
T49.4X5A
|
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
|
T49.5X5A
|
Adverse effect of ophthalmological drugs and preparations, initial encounter
|
T49.6X5A
|
Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
|
T49.7X5A
|
Adverse effect of dental drugs, topically applied, initial encounter
|
T49.8X5A
|
Adverse effect of other topical agents, initial encounter
|
T50.0X1A
|
Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), initial encounter
|
T50.0X2A
|
Poisoning by mineralocorticoids and their antagonists, intentional self-harm, initial encounter
|
T50.0X3A
|
Poisoning by mineralocorticoids and their antagonists, assault, initial encounter
|
T50.0X5A
|
Adverse effect of mineralocorticoids and their antagonists, initial encounter
|
T50.1X5A
|
Adverse effect of loop [high-ceiling] diuretics, initial encounter
|
T50.2X5A
|
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
|
T50.3X5A
|
Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
|
T50.4X5A
|
Adverse effect of drugs affecting uric acid metabolism, initial encounter
|
T50.5X5A
|
Adverse effect of appetite depressants, initial encounter
|
T50.6X5A
|
Adverse effect of antidotes and chelating agents, initial encounter
|
T50.7X5A
|
Adverse effect of analeptics and opioid receptor antagonists, initial encounter
|
T50.8X5A
|
Adverse effect of diagnostic agents, initial encounter
|
T50.A15A
|
Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
|
T50.A25A
|
Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
|
T50.A95A
|
Adverse effect of other bacterial vaccines, initial encounter
|
T50.B15A
|
Adverse effect of smallpox vaccines, initial encounter
|
T50.B95A
|
Adverse effect of other viral vaccines, initial encounter
|
T50.Z15A
|
Adverse effect of immunoglobulin, initial encounter
|
T50.Z95A
|
Adverse effect of other vaccines and biological substances, initial encounter
|
T50.905A
|
Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter
|
T50.995A
|
Adverse effect of other drugs, medicaments and biological substances, initial encounter
|
T51.3X1A
|
Toxic effect of fusel oil, accidental (unintentional), initial encounter
|
T51.3X2A
|
Toxic effect of fusel oil, intentional self-harm, initial encounter
|
T51.3X3A
|
Toxic effect of fusel oil, assault, initial encounter
|
T58.01XA
|
Toxic effect of carbon monoxide from motor vehicle exhaust, accidental (unintentional), initial encounter
|
T58.02XA
|
Toxic effect of carbon monoxide from motor vehicle exhaust, intentional self-harm, initial encounter
|
T58.03XA
|
Toxic effect of carbon monoxide from motor vehicle exhaust, assault, initial encounter
|
T58.11XA
|
Toxic effect of carbon monoxide from utility gas, accidental (unintentional), initial encounter
|
T58.12XA
|
Toxic effect of carbon monoxide from utility gas, intentional self-harm, initial encounter
|
T58.13XA
|
Toxic effect of carbon monoxide from utility gas, assault, initial encounter
|
T58.2X1A
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, accidental (unintentional), initial encounter
|
T58.2X2A
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, intentional self-harm, initial encounter
|
T58.2X3A
|
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, assault, initial encounter
|
T58.8X1A
|
Toxic effect of carbon monoxide from other source, accidental (unintentional), initial encounter
|
T58.8X2A
|
Toxic effect of carbon monoxide from other source, intentional self-harm, initial encounter
|
T58.8X3A
|
Toxic effect of carbon monoxide from other source, assault, initial encounter
|
T66.XXXA
|
Radiation sickness, unspecified, initial encounter
|
T75.01XA
|
Shock due to being struck by lightning, initial encounter
|
T75.09XA
|
Other effects of lightning, initial encounter
|
T75.4XXA
|
Electrocution, initial encounter
|
T79.0XXA
|
Air embolism (traumatic), initial encounter
|
T79.1XXA
|
Fat embolism (traumatic), initial encounter
|
T79.4XXA
|
Traumatic shock, initial encounter
|
T80.0XXA
|
Air embolism following infusion, transfusion and therapeutic injection, initial encounter
|
T80.211A
|
Bloodstream infection due to central venous catheter, initial encounter
|
T80.212A
|
Local infection due to central venous catheter, initial encounter
|
T80.218A
|
Other infection due to central venous catheter, initial encounter
|
T80.22XA
|
Acute infection following transfusion, infusion, or injection of blood and blood products, initial encounter
|
T80.29XA
|
Infection following other infusion, transfusion and therapeutic injection, initial encounter
|
T80.51XA
|
Anaphylactic reaction due to administration of blood and blood products, initial encounter
|
T80.52XA
|
Anaphylactic reaction due to vaccination, initial encounter
|
T80.59XA
|
Anaphylactic reaction due to other serum, initial encounter
|
T81.10XA
|
Postprocedural shock unspecified, initial encounter
|
T81.11XA
|
Postprocedural cardiogenic shock, initial encounter
|
T81.12XA
|
Postprocedural septic shock, initial encounter
|
T81.19XA
|
Other postprocedural shock, initial encounter
|
T81.40XA
|
Infection following a procedure, unspecified, initial encounter
|
T81.40XD
|
Infection following a procedure, unspecified, subsequent encounter
|
T81.40XS
|
Infection following a procedure, unspecified, sequela
|
T81.41XA
|
Infection following a procedure, superficial incisional surgical site, initial encounter
|
T81.41XD
|
Infection following a procedure, superficial incisional surgical site, subsequent encounter
|
T81.41XS
|
Infection following a procedure, superficial incisional surgical site, sequela
|
T81.42XA
|
Infection following a procedure, deep incisional surgical site, initial encounter
|
T81.42XD
|
Infection following a procedure, deep incisional surgical site, subsequent encounter
|
T81.42XS
|
Infection following a procedure, deep incisional surgical site, sequela
|
T81.43XA
|
Infection following a procedure, organ and space surgical site, initial encounter
|
T81.43XD
|
Infection following a procedure, organ and space surgical site, subsequent encounter
|
T81.43XS
|
Infection following a procedure, organ and space surgical site, sequela
|
T81.44XA
|
Sepsis following a procedure, initial encounter
|
T81.44XD
|
Sepsis following a procedure, subsequent encounter
|
T81.44XS
|
Sepsis following a procedure, sequela
|
T81.49XA
|
Infection following a procedure, other surgical site, initial encounter
|
T81.49XD
|
Infection following a procedure, other surgical site, subsequent encounter
|
T81.49XS
|
Infection following a procedure, other surgical site, sequela
|
T81.718A
|
Complication of other artery following a procedure, not elsewhere classified, initial encounter
|
T81.72XA
|
Complication of vein following a procedure, not elsewhere classified, initial encounter
|
T82.01XA
|
Breakdown (mechanical) of heart valve prosthesis, initial encounter
|
T82.02XA
|
Displacement of heart valve prosthesis, initial encounter
|
T82.03XA
|
Leakage of heart valve prosthesis, initial encounter
|
T82.110A
|
Breakdown (mechanical) of cardiac electrode, initial encounter
|
T82.111A
|
Breakdown (mechanical) of cardiac pulse generator (battery), initial encounter
|
T82.118A
|
Breakdown (mechanical) of other cardiac electronic device, initial encounter
|
T82.120A
|
Displacement of cardiac electrode, initial encounter
|
T82.121A
|
Displacement of cardiac pulse generator (battery), initial encounter
|
T82.128A
|
Displacement of other cardiac electronic device, initial encounter
|
T82.190A
|
Other mechanical complication of cardiac electrode, initial encounter
|
T82.191A
|
Other mechanical complication of cardiac pulse generator (battery), initial encounter
|
T82.198A
|
Other mechanical complication of other cardiac electronic device, initial encounter
|
T82.211A
|
Breakdown (mechanical) of coronary artery bypass graft, initial encounter
|
T82.212A
|
Displacement of coronary artery bypass graft, initial encounter
|
T82.213A
|
Leakage of coronary artery bypass graft, initial encounter
|
T82.221A
|
Breakdown (mechanical) of biological heart valve graft, initial encounter
|
T82.222A
|
Displacement of biological heart valve graft, initial encounter
|
T82.223A
|
Leakage of biological heart valve graft, initial encounter
|
T82.228A
|
Other mechanical complication of biological heart valve graft, initial encounter
|
T82.310A
|
Breakdown (mechanical) of aortic (bifurcation) graft (replacement), initial encounter
|
T82.311A
|
Breakdown (mechanical) of carotid arterial graft (bypass), initial encounter
|
T82.312A
|
Breakdown (mechanical) of femoral arterial graft (bypass), initial encounter
|
T82.318A
|
Breakdown (mechanical) of other vascular grafts, initial encounter
|
T82.320A
|
Displacement of aortic (bifurcation) graft (replacement), initial encounter
|
T82.321A
|
Displacement of carotid arterial graft (bypass), initial encounter
|
T82.322A
|
Displacement of femoral arterial graft (bypass), initial encounter
|
T82.328A
|
Displacement of other vascular grafts, initial encounter
|
T82.330A
|
Leakage of aortic (bifurcation) graft (replacement), initial encounter
|
T82.331A
|
Leakage of carotid arterial graft (bypass), initial encounter
|
T82.332A
|
Leakage of femoral arterial graft (bypass), initial encounter
|
T82.338A
|
Leakage of other vascular grafts, initial encounter
|
T82.390A
|
Other mechanical complication of aortic (bifurcation) graft (replacement), initial encounter
|
T82.391A
|
Other mechanical complication of carotid arterial graft (bypass), initial encounter
|
T82.392A
|
Other mechanical complication of femoral arterial graft (bypass), initial encounter
|
T82.398A
|
Other mechanical complication of other vascular grafts, initial encounter
|
T82.41XA
|
Breakdown (mechanical) of vascular dialysis catheter, initial encounter
|
T82.42XA
|
Displacement of vascular dialysis catheter, initial encounter
|
T82.43XA
|
Leakage of vascular dialysis catheter, initial encounter
|
T82.510A
|
Breakdown (mechanical) of surgically created arteriovenous fistula, initial encounter
|
T82.511A
|
Breakdown (mechanical) of surgically created arteriovenous shunt, initial encounter
|
T82.512A
|
Breakdown (mechanical) of artificial heart, initial encounter
|
T82.513A
|
Breakdown (mechanical) of balloon (counterpulsation) device, initial encounter
|
T82.514A
|
Breakdown (mechanical) of infusion catheter, initial encounter
|
T82.515A
|
Breakdown (mechanical) of umbrella device, initial encounter
|
T82.518A
|
Breakdown (mechanical) of other cardiac and vascular devices and implants, initial encounter
|
T82.520A
|
Displacement of surgically created arteriovenous fistula, initial encounter
|
T82.521A
|
Displacement of surgically created arteriovenous shunt, initial encounter
|
T82.522A
|
Displacement of artificial heart, initial encounter
|
T82.523A
|
Displacement of balloon (counterpulsation) device, initial encounter
|
T82.524A
|
Displacement of infusion catheter, initial encounter
|
T82.525A
|
Displacement of umbrella device, initial encounter
|
T82.528A
|
Displacement of other cardiac and vascular devices and implants, initial encounter
|
T82.530A
|
Leakage of surgically created arteriovenous fistula, initial encounter
|
T82.531A
|
Leakage of surgically created arteriovenous shunt, initial encounter
|
T82.532A
|
Leakage of artificial heart, initial encounter
|
T82.533A
|
Leakage of balloon (counterpulsation) device, initial encounter
|
T82.534A
|
Leakage of infusion catheter, initial encounter
|
T82.535A
|
Leakage of umbrella device, initial encounter
|
T82.538A
|
Leakage of other cardiac and vascular devices and implants, initial encounter
|
T82.590A
|
Other mechanical complication of surgically created arteriovenous fistula, initial encounter
|
T82.591A
|
Other mechanical complication of surgically created arteriovenous shunt, initial encounter
|
T82.592A
|
Other mechanical complication of artificial heart, initial encounter
|
T82.593A
|
Other mechanical complication of balloon (counterpulsation) device, initial encounter
|
T82.594A
|
Other mechanical complication of infusion catheter, initial encounter
|
T82.595A
|
Other mechanical complication of umbrella device, initial encounter
|
T82.598A
|
Other mechanical complication of other cardiac and vascular devices and implants, initial encounter
|
T82.6XXA
|
Infection and inflammatory reaction due to cardiac valve prosthesis, initial encounter
|
T82.7XXA
|
Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter
|
T82.817A
|
Embolism due to cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.818A
|
Embolism due to vascular prosthetic devices, implants and grafts, initial encounter
|
T82.827A
|
Fibrosis due to cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.837A
|
Hemorrhage due to cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.847A
|
Pain due to cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.857A
|
Stenosis of other cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.867A
|
Thrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter
|
T82.897A
|
Other specified complication of cardiac prosthetic devices, implants and grafts, initial encounter
|
T84.51XA
|
Infection and inflammatory reaction due to internal right hip prosthesis, initial encounter
|
T84.52XA
|
Infection and inflammatory reaction due to internal left hip prosthesis, initial encounter
|
T84.53XA
|
Infection and inflammatory reaction due to internal right knee prosthesis, initial encounter
|
T84.54XA
|
Infection and inflammatory reaction due to internal left knee prosthesis, initial encounter
|
T84.59XA
|
Infection and inflammatory reaction due to other internal joint prosthesis, initial encounter
|
T85.79XA
|
Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, initial encounter
|
T86.21 - T86.23
|
Heart transplant rejection - Heart transplant infection
|
T86.290
|
Cardiac allograft vasculopathy
|
T86.298
|
Other complications of heart transplant
|
T86.31 - T86.33
|
Heart-lung transplant rejection - Heart-lung transplant infection
|
T86.39
|
Other complications of heart-lung transplant
|
T88.0XXA
|
Infection following immunization, initial encounter
|
T88.59XA
|
Other complications of anesthesia, initial encounter
|
Z01.30
|
Encounter for examination of blood pressure without abnormal findings
|
Z01.31
|
Encounter for examination of blood pressure with abnormal findings
|
Z01.810
|
Encounter for preprocedural cardiovascular examination
|
Z01.818
|
Encounter for other preprocedural examination
|
Z01.82
|
Encounter for allergy testing
|
Z01.89
|
Encounter for other specified special examinations
|
Z09
|
Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
|
Z12.11
|
Encounter for screening for malignant neoplasm of colon
|
Z13.6
|
Encounter for screening for cardiovascular disorders
|
Z48.21 - Z48.24
|
Encounter for aftercare following heart transplant - Encounter for aftercare following lung transplant
|
Z48.280
|
Encounter for aftercare following heart-lung transplant
|
Z48.288
|
Encounter for aftercare following multiple organ transplant
|
Z48.290
|
Encounter for aftercare following bone marrow transplant
|
Z48.298
|
Encounter for aftercare following other organ transplant
|
Z51.11
|
Encounter for antineoplastic chemotherapy
|
Z52.4
|
Kidney donor
|
Z52.89
|
Donor of other specified organs or tissues
|
Z79.3
|
Long term (current) use of hormonal contraceptives
|
Z79.85
|
Long-term (current) use of injectable non-insulin antidiabetic drugs
|
Z79.891
|
Long term (current) use of opiate analgesic
|
Z79.899
|
Other long term (current) drug therapy
|
Z86.711
|
Personal history of pulmonary embolism
|
Z86.73
|
Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits
|
Z86.74
|
Personal history of sudden cardiac arrest
|
Z87.731
|
Personal history of (corrected) tracheoesophageal fistula or atresia
|
Z87.760
|
Personal history of (corrected) congenital diaphragmatic hernia or other congenital diaphragm malformations
|
Z94.1 - Z94.3
|
Heart transplant status - Heart and lungs transplant status
|
Z95.2 - Z95.4
|
Presence of prosthetic heart valve - Presence of other heart-valve replacement
|
Z95.811
|
Presence of heart assist device
|
Z95.812
|
Presence of fully implantable artificial heart
|
Z98.890
|
Other specified postprocedural states
|
Z98.891
|
History of uterine scar from previous surgery
|